[64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma

Zigeuner, 2012, Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010, Journal of clinical pathology, 65, 721, 10.1136/jclinpath-2012-200797

Clark, 2016, Renal cell cancer histological subtype distribution differs by race and sex, BJU international, 117, 260, 10.1111/bju.12950

Thompson, 2012, Metastatic potential of a renal mass according to original tumour size at presentation, BJU international, 109, 190, 10.1111/j.1464-410X.2011.10184.x

Allaf, 2013, Multiphasic enhancement patterns of small renal masses (</=4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma, Urology, 81, 1265, 10.1016/j.urology.2012.12.049

Rofsky, 2008, MR imaging of renal masses: correlation with findings at surgery and pathologic analysis, Radiographics, 28, 985, 10.1148/rg.284065018

Larson, 2004, Positron emission tomography for prostate, bladder, and renal cancer, Seminars in nuclear medicine, 34, 274, 10.1053/j.semnuclmed.2004.06.004

Mueller, 2006, Renal oncocytoma displaying intense activity on 18F-FDG PET, AJR American journal of roentgenology, 186, 269, 10.2214/AJR.05.0110

Gujral, 2006, Use of diagnostic percutaneous needle biopsy for indeterminate renal masses: Current practice in the UK, Journal of Endourology, 20, A189

Saigal, 2014, Utilization of renal mass biopsy in patients with renal cell carcinoma, Urology, 83, 774, 10.1016/j.urology.2013.10.073

Sokhi, 2012, Imaging in the follow-up of renal cell carcinoma, AJR American journal of roentgenology, 198, 1266, 10.2214/AJR.11.8381

Fishman, 2013, MDCT imaging following nephrectomy for renal cell carcinoma: protocol optimization and patterns of tumor recurrence, World J Radiol, 5, 436, 10.4329/wjr.v5.i11.436

Ivanovic, 2014, PET/CT with (124)I-cG250: great potential and some open questions, AJR American journal of roentgenology, 203, 261, 10.2214/AJR.14.12490

Javadi, 2015, Initial experience using 99mTcMIBI SPECT/CT for the differentiation of oncocytoma from renal cell carcinoma, Clinical nuclear medicine, 40, 309, 10.1097/RLU.0000000000000670

Whitesides, 2008, Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding, Chemical reviews, 108, 946, 10.1021/cr050262p

Supuran, 2008, Carbonic anhydrases: novel therapeutic applications for inhibitors and activators, Nature reviews Drug discovery, 7, 168, 10.1038/nrd2467

Belldegrun, 2003, Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy, Clinical cancer research, 9, 802

Signoretti, 2005, Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer, Clinical cancer research, 11, 3714, 10.1158/1078-0432.CCR-04-2019

Kwon, 2007, Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma, Journal of clinical oncology, 25, 4757, 10.1200/JCO.2007.12.1087

Bussink, 2008, Molecular aspects of tumour hypoxia, Molecular oncology, 2, 41, 10.1016/j.molonc.2008.03.006

Gawlinski, 1996, A reaction-diffusion model of cancer invasion, Cancer research, 56, 5745

Russo, 2007, Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial, The Lancet Oncology, 8, 304, 10.1016/S1470-2045(07)70044-X

Plimack, 2012, Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer, Biologics, 6, 395, 10.2147/BTT.S30413

Russo, 2013, Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial, Journal of clinical oncology, 31, 187, 10.1200/JCO.2011.41.2445

Larson, 2014, Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma, European journal of nuclear medicine and molecular imaging, 41, 985, 10.1007/s00259-013-2679-1

Zaknun, 2010, Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences, Nuclear medicine and biology, 37, 727, 10.1016/j.nucmedbio.2010.04.185

Pomper, 2015, Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer, Molecular imaging and biology, 17, 565, 10.1007/s11307-015-0850-8

Levine, 2015, Advancing novel molecular imaging agents from preclinical studies to firstin-humans phase I clinical trials in academia--a roadmap for overcoming perceived barriers, Bioconjugate chemistry, 26, 625, 10.1021/acs.bioconjchem.5b00105

Pomper, 2015, Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor, Oncotarget, 6, 33733, 10.18632/oncotarget.5254

Bormans, 2010, Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia, Nuclear medicine and biology, 37, 557, 10.1016/j.nucmedbio.2010.02.006

Scheuermann, 2015, Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation, Nature chemistry, 7, 241, 10.1038/nchem.2158

Neri, 2013, Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries, Angewandte Chemie (International ed in English), 52, 1384, 10.1002/anie.201204631

Scheuermann, 2014, DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries, Accounts of chemical research, 47, 1247, 10.1021/ar400284t

Lin, 2014, Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography, Journal of enzyme inhibition and medicinal chemistry, 29, 249, 10.3109/14756366.2013.773994

Bénard, 2015, Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging, Journal of nuclear medicine, 56, 1434, 10.2967/jnumed.114.153288

Askoxylakis, 2012, Optimization of a novel peptide ligand targeting human carbonic anhydrase IX, PloS one, 7, e38279, 10.1371/journal.pone.0038279

Lambin, 2015, [(18)F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models, Molecular imaging and biology, 17, 615, 10.1007/s11307-015-0831-y

Liu, 2015, Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo, Oncotarget, 6, 36139, 10.18632/oncotarget.5684

Zaidi, 2008, PET versus SPECT: strengths, limitations and challenges, Nuclear medicine communications, 29, 193, 10.1097/MNM.0b013e3282f3a515

Anderson, 2010, Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease, Chemical reviews, 110, 2858, 10.1021/cr900325h

Jurisson, 2013, Radiometals for combined imaging and therapy, Chemical reviews, 113, 858, 10.1021/cr3003104

Pomper, 2014, 64Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer, Journal of medicinal chemistry, 57, 2657, 10.1021/jm401921j

Old, 1990, Establishment and characterization of human renal cancer and normal kidney cell lines, Cancer research, 50, 5531

Neri, 2015, Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents, Journal of medicinal chemistry, 58, 8751, 10.1021/acs.jmedchem.5b00457

Scott, 2011, Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and 124 I-cG250 PET/CT, Urologic oncology, 29, 411, 10.1016/j.urolonc.2009.03.028

Barinka, 2012, Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II, Journal of biomolecular screening, 17, 1030, 10.1177/1087057112451924